Literature DB >> 8290544

Antigen-specific immunotherapy: is it a real possibility to combat T-cell-mediated autoimmunity?

R Tisch1, H O McDevitt.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8290544      PMCID： PMC42963          DOI： 10.1073/pnas.91.2.437

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  15 in total

1.  A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis.

Authors:  D E Smilek; D C Wraith; S Hodgkinson; S Dwivedy; L Steinman; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

2.  Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen.

Authors:  Z Y Zhang; C S Lee; O Lider; H L Weiner
Journal:  J Immunol       Date:  1990-10-15       Impact factor: 5.422

3.  Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model.

Authors:  P Aichele; D Kyburz; P S Ohashi; B Odermatt; R M Zinkernagel; H Hengartner; H Pircher
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

4.  Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.

Authors:  D L Kaufman; M Clare-Salzler; J Tian; T Forsthuber; G S Ting; P Robinson; M A Atkinson; E E Sercarz; A J Tobin; P V Lehmann
Journal:  Nature       Date:  1993-11-04       Impact factor: 49.962

5.  Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.

Authors:  R Tisch; X D Yang; S M Singer; R S Liblau; L Fugger; H O McDevitt
Journal:  Nature       Date:  1993-11-04       Impact factor: 49.962

6.  Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy.

Authors:  A Gaur; B Wiers; A Liu; J Rothbard; C G Fathman
Journal:  Science       Date:  1992-11-27       Impact factor: 47.728

7.  Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.

Authors:  Z J Zhang; L Davidson; G Eisenbarth; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

8.  Effects of oral administration of type II collagen on rheumatoid arthritis.

Authors:  D E Trentham; R A Dynesius-Trentham; E J Orav; D Combitchi; C Lorenzo; K L Sewell; D A Hafler; H L Weiner
Journal:  Science       Date:  1993-09-24       Impact factor: 47.728

9.  Antigen-driven bystander suppression after oral administration of antigens.

Authors:  A Miller; O Lider; H L Weiner
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

10.  Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.

Authors:  S J Khoury; W W Hancock; H L Weiner
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307
View more
  19 in total

Review 1.  Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes.

Authors:  Mark C Johnson; Bo Wang; Roland Tisch
Journal:  Hum Vaccin       Date:  2011-01-01

2.  Parameters influencing antigen-specific immunotherapy for Type 1 diabetes.

Authors:  Bo Wang; Roland Tisch
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  Parameters influencing antigen-specific immunotherapy for type 1 diabetes.

Authors:  Bo Wang; Roland Tisch
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

4.  Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes.

Authors:  J S Petersen; S Bregenholt; V Apostolopolous; D Homann; T Wolfe; A Hughes; K De Jongh; M Wang; T Dyrberg; M G Von Herrath
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

5.  Fine mapping of T-cell determinants of bovine beta-lactoglobulin.

Authors:  M Totsuka; A Ametani; S Kaminogawa
Journal:  Cytotechnology       Date:  1997       Impact factor: 2.058

6.  Inducing immune tolerance: a focus on Type 1 diabetes mellitus.

Authors:  Dan Xu; Suchitra Prasad; Stephen D Miller
Journal:  Diabetes Manag (Lond)       Date:  2013-09-01

7.  Epitope-specific tolerance induction with an engineered immunoglobulin.

Authors:  E T Zambidis; D W Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

8.  Homing of GAD65 specific autoimmunity and development of insulitis requires expression of both DQ8 and human GAD65 in transgenic mice.

Authors:  Raya B Elagin; Sadguna Balijepalli; Maria J Diacovo; Steinunn Baekkeskov; Juan C Jaume
Journal:  J Autoimmun       Date:  2009-03-16       Impact factor: 7.094

9.  Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice.

Authors:  M G von Herrath; T Dyrberg; M B Oldstone
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

10.  Transgenically induced GAD tolerance curtails the development of early beta-cell autoreactivities but causes the subsequent development of supernormal autoreactivities to other beta-cell antigens.

Authors:  Jide Tian; Hoa Dang; Harald von Boehmer; Elmar Jaeckel; Daniel L Kaufman
Journal:  Diabetes       Date:  2009-09-09       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.